SEGMENT AND GEOGRAPHIC INFORMATION (Tables)

12 Months Ended

Dec. 31, 2017

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Net sales and profit by reportable segment for the years ended December 31, 2017, 2016 and 2015 are as follows:

	Years Ended December 31,
	2017			2016			2015
	(In thousands)
Segment Net Sales
Codman Specialty Surgical	$	720,301		$	632,524		$	586,918
Orthopedics and Tissue Technologies	467,935			359,551			295,816
Total revenues	$	1,188,236		$	992,075		$	882,734
Segment Profit
Codman Specialty Surgical	$	292,971		$	256,629		$	242,479
Orthopedics and Tissue Technologies	129,697			103,852			87,844
Segment profit	422,668			360,481			330,323
Amortization	(20,370)			(13,862)			(9,953)
Corporate and other	(357,494		)	(231,279		)	(240,783		)
Operating income	$	44,804		$	115,340		$	79,587

The Company does not allocate any assets to the reportable segments, and, therefore, no asset information is reported to the chief operating decision maker and disclosed in the financial information for each segment.

The Company attributes revenue to geographic areas based on the location of the customer. There are certain revenues managed by the various U.S. segments above that are generated from non-U.S. customers and therefore included in Europe and the Rest of World revenues below.

Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:

	United States*		Europe		Rest of the World		Consolidated
	(In thousands)
Total revenue, net:
2017	$	894,260	$	150,147	$	143,829	$	1,188,236
2016	765,608		120,588		105,879		992,075
2015	680,824		103,057		98,853		882,734
Total long-lived assets:
2017	$	247,154	$	30,942	$	7,233	$	285,329
2016	213,898		18,970		1,235		234,103

* Includes long-lived assets in Puerto Rico.